日联科技公告，公司拟以集中竞价交易方式回购股份，回购金额不低于1000万元，不超过2000万元，资 金来源为自有资金和自筹资金。回购价格不超过101.87元/股，回购股份将用于股权激励，并在股份回 购实施结果暨股份变动公告披露后三年内完成股份转让。若未能在规定期限内转让完毕，未转让股份将 被注销。回购期限为自董事会审议通过最终股份回购方案之日起不超过12个月。公司控股股东、其他持 股5%以上股东、董事、监事及高级管理人员在未来3个月、未来6个月内暂无减持公司股份的计划。 ...

对于非累积投票议案，填报表决意见：同意、反对、弃权。 股东对总议案与具体提案重复投票时，以第一次有效投票为准。如股东先对 具体提案投票表决，再对总议案投票表决，则以已投票表决的具体提案的表决意 见为准，其他未表决的提案以总议案的表决意见为准；如先对总议案投票表决， 再对具体提案投票表决，则以总议案的表决意见为准。 二、通过深交所交易系统投票的程序 三、通过深交所互联网投票系统投票的程序 日）上午 9:15，结束时间为 2025 年 7 月 9 日（现场股东大会召开当日）下午 网络服务身份认证业务指引（2016 年 4 月修订）》的规定办理身份认证，取得"深 交所数字证书"或"深交所投资者服务密码"。具体的身份认证流程可登录互联 网投票系统 http://wltp.cninfo.com.cn 规则指引栏目查阅。 http://wltp.cninfo.com.cn 在规定时间内通过深交所互联网投票系统进行投 票。 附件二：授权委托书 股东授权委托书 兹委托 先生（女士）代表本人（本单位）参加浪潮电子信息产业 股份有限公司 2025 年第二次临时股东大会，特授权如下： 受托人姓名： 受托人身份证号码： 受托人具有表 ...

Core Viewpoint - The company has completed the cancellation of repurchased shares, reducing its total share capital from 1,169,323,576 shares to 1,158,443,576 shares, which is expected to enhance earnings per share and improve shareholder returns [1][2][3] Summary by Sections 1. Approval and Implementation of Share Repurchase - The company approved a share repurchase plan on March 27, 2024, allowing for the repurchase of shares at a price not exceeding RMB 20 per share, with a total repurchase fund of at least RMB 153 million [1][2] - The actual repurchase involved 10,880,000 shares, accounting for 0.93% of the total share capital, with a total transaction amount of approximately RMB 153 million [1][2] 2. Cancellation of Repurchased Shares - The cancellation of the repurchased shares was confirmed by the China Securities Depository and Clearing Corporation on June 19, 2025, in compliance with relevant laws and regulations [2][3] - The number of shares canceled was 10,880,000, which represented 0.93% of the total share capital before cancellation [2] 3. Changes in Shareholding Structure - Following the cancellation, the total number of shares decreased to 1,158,443,576, with the structure remaining compliant with listing requirements [2][3] - The proportion of unrestricted circulating shares slightly decreased from 99.9628% to 99.9624% after the cancellation [2] 4. Impact of Share Cancellation - The cancellation is expected to enhance the company's earnings per share and improve returns for shareholders without significantly affecting the company's financial status or future development [3] - The cancellation will not harm the interests of shareholders, particularly minority shareholders, and will not lead to changes in the controlling shareholder or actual controller [3] 5. Follow-up Arrangements - The company will proceed with necessary changes in business registration and articles of association as per legal requirements following the completion of the share cancellation [3]

Core Viewpoint - The company has approved the 2024 profit distribution plan, which includes a cash dividend of 1.30 RMB per 10 shares, totaling 20,049,134.69 RMB, with adjustments based on changes in total share capital [1][2][3]. Group 1: Profit Distribution Plan - The profit distribution plan was approved at the 2024 annual general meeting, with a base of 154,224,113 shares, distributing 1.30 RMB per 10 shares, totaling 20,049,134.69 RMB [1][2]. - Due to the conversion of convertible bonds, the total share capital increased to 158,502,693 shares, leading to an adjusted distribution of 1.270290 RMB per 10 shares for the actual participating shares of 157,831,146 [1][3][4]. Group 2: Ex-Dividend and Record Dates - The record date for the profit distribution is set for June 26, 2025, and the ex-dividend date is June 27, 2025 [5][6]. Group 3: Share Repurchase and Adjustments - The company plans to repurchase shares with a total amount between 30 million RMB and 50 million RMB, with a maximum repurchase price of 53.35 RMB per share, subject to adjustments based on dividend distributions [8][9].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会、全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 科兴生物制药股份有限公司（以下简称"公司"）2024年年度权益分派已实施完毕，公司以集中竞价交 易方式回购股份价格上限由不超过人民币46.83元/股（含）调整为不超过人民币46.75元/股（含），回 购价格上限调整起始日为2025年6月12日（2024年年度权益分派除权除息日）。 一、回购股份的基本情况 公司于2025年3月17日召开第二届董事会第二十一次会议，审议通过了《关于以集中竞价交易方式回购 公司股份方案的议案》，同意公司使用不低于人民币3,000万元（含），不超过人民币6,000万元（含） 的自有资金和回购专项贷款通过上海证券交易所交易系统以集中竞价交易方式回购公司股份，本次回购 股份在未来适宜时机用于股权激励或员工持股计划，并在公司披露股份回购实施结果暨股份变动公告日 之后的三年内予以转让；若公司本次回购的股份未能在上述三年内转让完毕，公司将依法履行减少注册 资本的程序，未转让股份将在三年期限届 ...

Group 1 - The company announced a share repurchase plan with a total expected amount between 75 million and 150 million RMB, with a repurchase period from September 20, 2024, to September 19, 2025 [1] - The repurchase is intended for employee stock ownership plans or equity incentives, with a maximum repurchase price set at 5.00 RMB per share [1] - As of June 20, 2025, the company has repurchased a total of 20,592,200 shares, accounting for 1.001% of the total share capital, with a total expenditure of 80,457,115.00 RMB [3] Group 2 - The company held a board meeting on October 18, 2024, to change the purpose of the repurchased shares from solely for employee stock ownership plans to include equity incentives [2] - Following the distribution of cash dividends, the maximum repurchase price was adjusted from 5.00 RMB to 4.99 RMB per share on January 24, 2025, and further adjusted to 4.96 RMB on June 17, 2025 [2][3] - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations regarding the progress of the share repurchase [4]

证券代码：688008 证券简称：澜起科技 公告编号：2025-028 澜起科技股份有限公司 关于 2025 年第二次以集中竞价交易方式 回购 A 股股份的预案 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ●回购股份金额：不低于人民币 2 亿元（含），不超过人民币 4 亿元（含） ●回购股份资金来源：公司自有资金 ●回购股份用途：本次回购股份将用于减少公司注册资本 ●回购股份价格：不超过人民币 118 元/股（含） ●回购股份方式：通过上海证券交易所系统以集中竞价交易方式回购 ●回购股份期限：自公司股东大会审议通过本次回购方案之日起 12 个月内。 本次回购方案不影响 2025 年第一次回购方案的独立实施，本次回购方案将于股东 大会审议通过后且公司 2025 年第一次回购方案实施完毕之后开始实施。 ●相关股东是否存在减持计划： 没有减持计划。 动人 WLT Partners,L.P.、中国电子投资控股有限公司及其一致行动人嘉兴芯电投资 合伙企业（有限合伙）回复称：未来 3 个月、未来 6 个月内如有减持 ...

本公司董事会、全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ? 科兴生物制药股份有限公司（以下简称"公司"）2024 年年度权益分派 已实施完毕，公司以集中竞价交易方式回购股份价格上限由不超过人民币 46.83 元/股（含）调整为不超过人民币 46.75 元/股（含），回购价格上限调整起始日 为 2025 年 6 月 12 日（2024 年年度权益分派除权除息日）。 一、回购股份的基本情况 公司于 2025 年 3 月 17 日召开第二届董事会第二十一次会议，审议通过了 《关 证券代码：688136 证券简称：科兴制药 公告编号：2025-036 科兴生物制药股份有限公司 关于 2024 年年度权益分派实施后调整回购价格上限的公告 （公告编号：2025-033）。 鉴于上述权益分派事项已实施完毕，根据《回购方案》，若公司在回购股份 期内发生派发红利、送红股、公积金转增股本等除权除息事项的，自股价除权除 息之日起，按照中国证监会及上海证券交易所的相关规定相应调整回购价格上限。 三、本次回购股份价格上限的调整 根据《回购方 ...

证券代码：688297 证券简称：中无人机 中航（成都）无人机系统股份有限公司 会议资料 中航（成都）无人机系统股份有限公司 2025 年第一次临时股东大会会议资料 中航（成都）无人机系统股份有限公司 2025 年第一次临时股东大会会议须知 ......... 3 中航（成都）无人机系统股份有限公司 2025 年第一次临时股东大会会议议程 ......... 5 中航（成都）无人机系统股份有限公司 2025 年第一次临时股东大会会议资料 中航（成都）无人机系统股份有限公司 为维护广大投资者的合法权益，保障股东在中航（成都）无人机系统股份有 限公司（以下简称"公司"或"本公司"）本次股东大会期间依法行使权利，根 据《中华人民共和国公司法》、 《中华人民共和国证券法》、 《上市公司股东大会规 则》、公司《章程》、公司《股东大会议事规则》等有关规定，特制定本会议须知： 一、公司负责本次股东大会的议程安排和会务工作，出席会议人员应当配合 公司工作人员安排，共同维护好会议秩序。 二、为保证股东大会的正常秩序，除出席会议的股东或者股东代理人、董事、 监事、董事会秘书、其他高级管理人员、见证律师、本次会议议程有关人员及会 ...

Group 1 - The company has approved a share repurchase plan using its own funds ranging from RMB 25 million to RMB 50 million, with a maximum repurchase price of RMB 53.31 per share, aimed at employee stock ownership plans or equity incentives [1][2] - As of August 16, 2024, the company has repurchased a total of 1,291,428 shares, which will not participate in profit distribution, leading to a differentiated dividend distribution for the fiscal year 2024 [2] - The actual number of shares participating in the profit distribution is 38,708,572 shares, calculated by deducting the repurchased shares from the total share capital of 40 million shares [2][3] Group 2 - The company plans to distribute a cash dividend of RMB 1.00 per 10 shares (including tax) based on the adjusted total share capital after accounting for repurchased shares [2] - The cash dividend per share is calculated to be RMB 0.1, with the reference price for ex-dividend trading set at RMB 39.62 per share, reflecting minimal impact from the repurchased shares on the market price [3] - The sponsor institution confirms that the differentiated dividend distribution complies with relevant regulations and does not harm the interests of the company or its shareholders [3]